The global diabetic foot ulcers treatment market was USD 1834.51 million in 2018 and is estimated to reach USD 3342.80 million by 2025 at a CAGR of 8.95% during the forecast period
Growth by Region
North America held the major share of the global diabetic foot ulcers treatment market accounting for more than 35% in 2018. EMEA held the second largest share followed by Asia-Pacific. The supremacy of the Americas is due to the US, which is the world’s largest pharmaceuticals market.
Drivers and Restraints
One of the significant factors contributing to the growth of the market is the strong drug development pipeline. Moreover, an extensive rise in chronic diabetes affecting thousands of people on a yearly basis, and rapidly growing geriatric population which further leads to the development of pressure based ulcers and bruises are the other factors driving the market growth. However, high costs associated with the ulcer treatments is hampering the market.
Industry Trends and Updates
The growing wound healing therapeutics is one of the major trends being witnessed in the global diabetic foot ulcers market during the forecast period. The neuro-ischemic and ischemic ulcer therapeutics segment held the largest market share contributing to over 64% of the market in 2017 and will continue to dominate the global market throughout the forecast period.
Global Diabetic Foot Ulcers Treatment Market – by Product Type, Ulcer, End User, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2018 - 2025)
1. Research Methodology
2. Executive Summary
3. Market Overview
3.1. Definition
3.2. Industry Value Chain Analysis
3.3. Porter's 5 Forces
3.4. Regulations
4. Market Dynamics
4.1. Introduction
4.2. Drivers
4.3. Constraints
4.4. Trends
5. Global Diabetic Foot Ulcers Treatment Market Segmentation, Forecasts and Trends - by Product Type
5.1. Wound Care Dressings
5.2. Biologics
5.3. Therapy Devices
5.4. Others
6. Global Diabetic Foot Ulcers Treatment Market Segmentation, Forecasts and Trends - by Ulcer
6.1. Neuropathic Ulcers
6.2. Neuro-Ischemic Ulcers
7. Global Diabetic Foot Ulcers Treatment Market Segmentation, Forecasts and Trends - by End User
7.1. Hospital
7.2. Clinics
7.3. Ambulatory Surgical Center
7.4. Homecare Setting
8. Global Diabetic Foot Ulcers Treatment Market Segmentation, Forecasts and Trends - by Region
8.1. North America
8.1.1. U.S.
8.1.2. Canada
8.1.3. Mexico
8.2. Europe
8.2.1. UK
8.2.2. France
8.2.3. Germany
8.2.4. Italy
8.2.5. Others
8.3. Asia Pacific
8.3.1. India
8.3.2. China
8.3.3. Japan
8.3.4. Australia
8.3.5. Others
8.4. South America
8.4.1. Brazil
8.4.2. Argentina
8.4.3. Others
8.5. Middle East and Africa
8.5.1. South Africa
8.5.2. UAE
8.5.3. Saudi Arabia
8.5.4. Egypt
8.5.5. Others
9. Competitive Intelligence
9.1. Company Market Share Analysis
9.2. Industry M&As, Consolidations
10. Company Profiles
10.1. ANP Technologies Inc
10.2. Boston Therapeutics Inc
10.3. CardioVascular BioTherapeutics Inc
10.4. Chrysalis BioTherapeutics Inc
10.5. CytoTools AG
10.6. Energenesis Biomedical Co Ltd
10.7. EyeGene Inc
10.8. FirstString Research Inc
10.9. Genentech Inc
10.10. GlaxoSmithKline Plc
10.11. Human Stem Cells Institute
10.12. Izun Pharmaceuticals Corp
10.13. Lakewood-Amedex Inc
10.14. MallInckrodt Plc
10.15. MediWound Ltd
10.16. NovaLead Pharma Pvt Ltd
10.17. OliX Pharmaceuticals Inc
10.18. Oneness Biotech Co Ltd
10.19. Pherecydes Pharma SA
10.20. ProMetic Life Sciences Inc
10.21. Serodus ASA
10.22. Stempeutics Research Pvt Ltd
10.23. TechnoPhage SA
10.24. Topadur Pharma AG
10.25. USV Pvt Ltd
10.26. ViroMed Co Ltd
10.27. Others
11. Investment Opportunities